Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · iSpecimen Inc. (ISPC)

iSpecimen Gets Nasdaq Extension to Nov. 25, 2026 to Fix Stockholders' Equity Gap

Mixed Impact 4 of 5 legal/regulatory Written later

iSpecimen received a Nasdaq letter dated September 8, 2026, granting an extension until November 25, 2026 to regain compliance with the minimum stockholders' equity requirement. The company says it plans a best-efforts public offering of approximately $5 million in gross proceeds, but the filing states there is no assurance it will regain or maintain compliance, and shareholders could face delisting if it fails to do so.

Key points

  • Nasdaq first notified the company of noncompliance on May 29, 2026, under Listing Rule 5550(b), which requires at least $2,500,000 in stockholders' equity.
  • The company cites a private placement that closed May 11, 2026, with gross proceeds of approximately $2.5 million, and a planned public offering of approximately $5 million.
  • Projections show stockholders' equity of approximately $5.1 million through June 30, 2027, per the filing.
  • The Deficiency Letter has no immediate effect on trading of the common stock on the Nasdaq Capital Market.

The filing

CompanyiSpecimen Inc. (ISPC)
Form8-K, current report
Filed with the SECSep 10, 2026, 5:00 PM ET
Accession number0001213900-26-098847

Items reported: 3.01 Delisting / Listing Rule Notice

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.